Vimarsana
Biggest News Aggregation in the World

Page 47 - Devika Syamnath News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Devika Syamnath. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Devika Syamnath Today - Breaking & Trending Today

Honda to focus on selling hybrid vehicles, light trucks in US this year - Vimarsana News

Honda to focus on selling hybrid vehicles, light trucks in US this year

Honda Motor said on Thursday it would continue to focus on sales of hybrid models and light trucks in the United States this year in response to more demand for those vehicles. Legacy...

Bank of America profit falls - Vimarsana News

Bank of America profit falls

Bank of America's fourth-quarter profit shrank as the lender took $2.1 billion in charges to refill a government deposit insurance fund The second-largest U.S. lender posted net income...

India's Tata Consumer Products to buy Capital Foods for $616 million - Vimarsana News

India's Tata Consumer Products to buy Capital Foods for $616 million

India's Tata Consumer Products will buy Capital Foods for an enterprise value of 51 billion rupees , it said via an exchange filing on Friday....

BofA profit falls on $3.7 billion in charges, sees resilient US economy - Vimarsana News

BofA profit falls on $3.7 billion in charges, sees resilient US economy

-Bank of America's fourth-quarter profit shrank as the lender took $3.7 billion in one-off charges on Friday, and its finance chief expressed optimism about the U.S. economic outlook.... -January 12, 2024 at 09:24 am EST - MarketScreener

Oxford starts human testing of Nipah virus vaccine - Vimarsana News

Oxford starts human testing of Nipah virus vaccine

Nipah was first identified about 25 years ago in Malaysia and has led to outbreaks in Bangladesh, India and Singapore. The first participants in the Oxford trial received doses of the vaccine over the last week. The shot is based on the same technology as the one used in AstraZeneca and Serum Institute of India's COVID-19 shots.

Source: yahoo.com